Cargando…
The highly selective Bruton tyrosine kinase inhibitor acalabrutinib leaves macrophage phagocytosis intact
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Fondazione Ferrata Storti
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9152969/ https://www.ncbi.nlm.nih.gov/pubmed/35172559 http://dx.doi.org/10.3324/haematol.2021.279560 |
_version_ | 1784717752827641856 |
---|---|
author | Pinney, Jonathan J. Blick-Nitko, Sara K. Baran, Andrea M. Peterson, Derick R. Whitehead, Hannah E. Izumi, Raquel Munugalavadla, Veerendra VanDerMeid, Karl R. Barr, Paul M. Zent, Clive S. Elliott, Michael R. Chu, Charles C. |
author_facet | Pinney, Jonathan J. Blick-Nitko, Sara K. Baran, Andrea M. Peterson, Derick R. Whitehead, Hannah E. Izumi, Raquel Munugalavadla, Veerendra VanDerMeid, Karl R. Barr, Paul M. Zent, Clive S. Elliott, Michael R. Chu, Charles C. |
author_sort | Pinney, Jonathan J. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9152969 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Fondazione Ferrata Storti |
record_format | MEDLINE/PubMed |
spelling | pubmed-91529692022-06-21 The highly selective Bruton tyrosine kinase inhibitor acalabrutinib leaves macrophage phagocytosis intact Pinney, Jonathan J. Blick-Nitko, Sara K. Baran, Andrea M. Peterson, Derick R. Whitehead, Hannah E. Izumi, Raquel Munugalavadla, Veerendra VanDerMeid, Karl R. Barr, Paul M. Zent, Clive S. Elliott, Michael R. Chu, Charles C. Haematologica Letter to the Editor Fondazione Ferrata Storti 2022-02-17 /pmc/articles/PMC9152969/ /pubmed/35172559 http://dx.doi.org/10.3324/haematol.2021.279560 Text en Copyright© 2022 Ferrata Storti Foundation https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution Noncommercial License (by-nc 4.0) which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited. |
spellingShingle | Letter to the Editor Pinney, Jonathan J. Blick-Nitko, Sara K. Baran, Andrea M. Peterson, Derick R. Whitehead, Hannah E. Izumi, Raquel Munugalavadla, Veerendra VanDerMeid, Karl R. Barr, Paul M. Zent, Clive S. Elliott, Michael R. Chu, Charles C. The highly selective Bruton tyrosine kinase inhibitor acalabrutinib leaves macrophage phagocytosis intact |
title | The highly selective Bruton tyrosine kinase inhibitor acalabrutinib leaves macrophage phagocytosis intact |
title_full | The highly selective Bruton tyrosine kinase inhibitor acalabrutinib leaves macrophage phagocytosis intact |
title_fullStr | The highly selective Bruton tyrosine kinase inhibitor acalabrutinib leaves macrophage phagocytosis intact |
title_full_unstemmed | The highly selective Bruton tyrosine kinase inhibitor acalabrutinib leaves macrophage phagocytosis intact |
title_short | The highly selective Bruton tyrosine kinase inhibitor acalabrutinib leaves macrophage phagocytosis intact |
title_sort | highly selective bruton tyrosine kinase inhibitor acalabrutinib leaves macrophage phagocytosis intact |
topic | Letter to the Editor |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9152969/ https://www.ncbi.nlm.nih.gov/pubmed/35172559 http://dx.doi.org/10.3324/haematol.2021.279560 |
work_keys_str_mv | AT pinneyjonathanj thehighlyselectivebrutontyrosinekinaseinhibitoracalabrutinibleavesmacrophagephagocytosisintact AT blicknitkosarak thehighlyselectivebrutontyrosinekinaseinhibitoracalabrutinibleavesmacrophagephagocytosisintact AT baranandream thehighlyselectivebrutontyrosinekinaseinhibitoracalabrutinibleavesmacrophagephagocytosisintact AT petersonderickr thehighlyselectivebrutontyrosinekinaseinhibitoracalabrutinibleavesmacrophagephagocytosisintact AT whiteheadhannahe thehighlyselectivebrutontyrosinekinaseinhibitoracalabrutinibleavesmacrophagephagocytosisintact AT izumiraquel thehighlyselectivebrutontyrosinekinaseinhibitoracalabrutinibleavesmacrophagephagocytosisintact AT munugalavadlaveerendra thehighlyselectivebrutontyrosinekinaseinhibitoracalabrutinibleavesmacrophagephagocytosisintact AT vandermeidkarlr thehighlyselectivebrutontyrosinekinaseinhibitoracalabrutinibleavesmacrophagephagocytosisintact AT barrpaulm thehighlyselectivebrutontyrosinekinaseinhibitoracalabrutinibleavesmacrophagephagocytosisintact AT zentclives thehighlyselectivebrutontyrosinekinaseinhibitoracalabrutinibleavesmacrophagephagocytosisintact AT elliottmichaelr thehighlyselectivebrutontyrosinekinaseinhibitoracalabrutinibleavesmacrophagephagocytosisintact AT chucharlesc thehighlyselectivebrutontyrosinekinaseinhibitoracalabrutinibleavesmacrophagephagocytosisintact AT pinneyjonathanj highlyselectivebrutontyrosinekinaseinhibitoracalabrutinibleavesmacrophagephagocytosisintact AT blicknitkosarak highlyselectivebrutontyrosinekinaseinhibitoracalabrutinibleavesmacrophagephagocytosisintact AT baranandream highlyselectivebrutontyrosinekinaseinhibitoracalabrutinibleavesmacrophagephagocytosisintact AT petersonderickr highlyselectivebrutontyrosinekinaseinhibitoracalabrutinibleavesmacrophagephagocytosisintact AT whiteheadhannahe highlyselectivebrutontyrosinekinaseinhibitoracalabrutinibleavesmacrophagephagocytosisintact AT izumiraquel highlyselectivebrutontyrosinekinaseinhibitoracalabrutinibleavesmacrophagephagocytosisintact AT munugalavadlaveerendra highlyselectivebrutontyrosinekinaseinhibitoracalabrutinibleavesmacrophagephagocytosisintact AT vandermeidkarlr highlyselectivebrutontyrosinekinaseinhibitoracalabrutinibleavesmacrophagephagocytosisintact AT barrpaulm highlyselectivebrutontyrosinekinaseinhibitoracalabrutinibleavesmacrophagephagocytosisintact AT zentclives highlyselectivebrutontyrosinekinaseinhibitoracalabrutinibleavesmacrophagephagocytosisintact AT elliottmichaelr highlyselectivebrutontyrosinekinaseinhibitoracalabrutinibleavesmacrophagephagocytosisintact AT chucharlesc highlyselectivebrutontyrosinekinaseinhibitoracalabrutinibleavesmacrophagephagocytosisintact |